The results of another study revealed that diabetic individuals with acute myocardial infarction (AMI) who underwent primary PCI and were treated with SGLT-Is had lower CRP levels on admission compared to those in the control group, with a statistically significant difference (P < 0.001). The gene discussed is CRP; the disease is myocardial infarction.